| NCT Number | NCT07544680 |
| Lead Sponsor | Exact Sciences Corporation |
| Conditions | Abnormal Uterine Bleeding (AUB), Endometrial Cancer, Atypical Endometrial Hyperplasia, Endometrial Hyperplasia With Atypia, Endometrial Intraepithelial Neoplasia |
| Enrollment | 4,200 participants |
| Start Date | 2026-03-10 |
| Primary Completion | 2028-04-24 (estimated) |
| Study Completion | 2028-04-24 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-03 |